Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Circulating CD56(dim) NK cells expressing perforin are increased in progressive multiple sclerosis.
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System.
[Pregnancy and delivery in women with multiple sclerosis: a retrospective analysis.]
Early diagnosis of Balo's concentric sclerosis by diffusion tensor tractography: a case report and literature review.
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Oligodendrogenesis in the fornix of adult mouse brain; the effect of LPS-induced inflammatory stimulation.
Oligodendrocyte Development and Plasticity.
Human adipose stromal/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.
The detection of THC, CBD and CBN in the oral fluid of Sativex(®) patients using two on-site screening tests and LC-MS/MS.
The Dopaminergic System in Autoimmune Diseases.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Is malnutrition a problem for multiple sclerosis patients?
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Commentary on neuromyelitis optica associated with painful paroxysmal dystonia: case report and literature review.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.
Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis.
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients: An Open-Label Multicenter Study.
Assessing risks of multiple sclerosis therapies.
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
Pages
« first
‹ previous
…
533
534
535
536
537
538
539
540
541
…
next ›
last »